| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9975120 | The Journal of Heart and Lung Transplantation | 2005 | 6 Pages |
Abstract
The results demonstrate that cyclosporine-treated lung transplant recipients have increased plasma levels of ET-1 and a blunted response to ET-A receptor blockade compared with healthy subjects. In contrast, we found no evidence for an increased basal vascular resistance in transplant recipients. These alterations in endothelin handling may contribute to the development of transplant-associated hypertension.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Martin MD, Anneli PhD, Folke MD, PhD, Peter MD, PhD, Anders MD, PhD,